Internal medicine, Endocrinology, Molecular biology, Cyclooxygenase and Platelet are his primary areas of study. His Endocrinology research is multidisciplinary, incorporating perspectives in Receptor and Cyclic adenosine monophosphate. His Molecular biology research is multidisciplinary, incorporating elements of Foreskin, Cell and Immunoprecipitation.
Cyclooxygenase is the subject of his research, which falls under Biochemistry. His work deals with themes such as Monoclonal antibody and Monocyte, which intersect with Biochemistry. His research integrates issues of Radioimmunoassay and Chromatography in his study of Platelet.
Jacques Maclouf mostly deals with Internal medicine, Biochemistry, Endocrinology, Platelet and Arachidonic acid. His Internal medicine study frequently draws parallels with other fields, such as Cardiology. He combines subjects such as Molecular biology, Antiserum and Leukotriene with his study of Biochemistry.
His work on Prostaglandin, Urinary system and Prostaglandin E2 as part of general Endocrinology study is frequently connected to Coronary perfusion pressure, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His research in Platelet intersects with topics in Biophysics and Cell biology. His Arachidonic acid research is multidisciplinary, incorporating elements of Cyclooxygenase, Lipoxygenase and Metabolism.
His scientific interests lie mostly in Internal medicine, Endocrinology, Molecular biology, Biochemistry and Nitric oxide. The various areas that Jacques Maclouf examines in his Internal medicine study include Cyclooxygenase, Immunology and Cardiology. The study incorporates disciplines such as Arachidonic acid and MAPK/ERK pathway in addition to Endocrinology.
His biological study spans a wide range of topics, including Endothelial stem cell, Phosphoprotein phosphatase and Monocyte. His study on Phosphorylation, Oxidative stress and Enzyme is often connected to Cortactin as part of broader study in Biochemistry. His Nitric oxide research integrates issues from Inflammation, Lipopolysaccharide and Macrophage.
His main research concerns Internal medicine, Endocrinology, Molecular biology, Nitric oxide and Nitric oxide synthase. The study of Internal medicine is intertwined with the study of Immunology in a number of ways. The Endocrinology study combines topics in areas such as Receptor and Cell biology.
The concepts of his Molecular biology study are interwoven with issues in Protein kinase C, Protein kinase A, Phosphorylation and Thromboxane receptor, Thromboxane A2. His Nitric oxide research is multidisciplinary, incorporating perspectives in Cyclooxygenase, Macrophage and Cytokine. His Nitric oxide synthase research incorporates themes from Prostaglandin E2 and Inflammation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Bart Staels;Bart Staels;Wolfgang Koenig;Aïda Habib;Régine Merval.
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases.
P Patrignani;M R Panara;A Greco;O Fusco.
Journal of Pharmacology and Experimental Therapeutics (1994)
Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure.
Ziad Mallat;Ivan Philip;Maryline Lebret;Didier Chatel.
Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
D Praticò;L Iuliano;A Mauriello;L Spagnoli.
Journal of Clinical Investigation (1997)
Cyclooxygenase-2 Is Widely Expressed in Atherosclerotic Lesions Affecting Native and Transplanted Human Coronary Arteries and Colocalizes With Inducible Nitric Oxide Synthase and Nitrotyrosine Particularly in Macrophages
Christopher S. R. Baker;Roger J. C. Hall;Thomas J. Evans;Ariela Pomerance.
Arteriosclerosis, Thrombosis, and Vascular Biology (1999)
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
Zhaoyue Wang;G. Ciabattoni;C. Creminon;J. Lawson.
Journal of Pharmacology and Experimental Therapeutics (1995)
Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2.
A Habib;C Créminon;Y Frobert;J Grassi.
Journal of Biological Chemistry (1993)
Stimulation of leukotriene biosynthesis in human blood leukocytes by platelet-derived 12-hydroperoxy-icosatetraenoic acid
J Maclouf;B F de Laclos;P Borgeat.
Proceedings of the National Academy of Sciences of the United States of America (1982)
Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation.
Roger Cariou;Gérard Tobelem;Sylvia Bellucci;Jeannette Soria.
Thrombosis and Haemostasis (1988)
The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis
Ziad Mallat;Tatsuji Nakamura;Jeanny Ohan;Guy Lesèche.
Journal of Clinical Investigation (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: